Castle Biosciences Inc

Research Castle Biosciences Inc (CSTL) on Bullrun: market cap USD 737.63M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCSTL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 737.63M
• Financial periodFY2025
• RevenueUSD 344.23M
• Revenue growth3.7%
• Net income-USD 24.16M
• Free cash flowUSD 28.33M
• Gross margin79.4%

Valuation Snapshot

latest market cap is USD 737.63M.

About Castle Biosciences Inc

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma;

Frequently asked questions

What is Castle Biosciences Inc's market cap?

Castle Biosciences Inc's market capitalization is USD 737.63M.

What does Castle Biosciences Inc do?

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma.